Successful eradication
|
16 (Corral, 2008) [10]
|
Unknown – lived in BVI
|
Meropenem 2 g tds
|
19 days
|
TMP/SMX 960 mg bd
|
19 days
|
Minocycline 100 mg bd
|
Minocycline 100 mg bd
|
Tobramycin (neb)a 80 mg bd
|
20 (O’Sullivan, 2011) [13]
|
3 months
|
Imipenem
|
14 days
|
Meropenem (neb)
|
28 days
|
Ceftazidime
|
TMP/SMX 960 mg bd
|
2 years
|
4 (Visca, 2001) [15]
|
12 months
|
Ceftazidime
|
42 days
|
TMP/SMX 960 mg bd
|
210 days
|
TMP/SMX 960 mg bd
|
Doxycycline
|
Chloramphenicol
|
13 (Asiah, 2006) [8]
|
12 months
|
Ceftazidime
|
56 days
|
TMP/SMX 960 mg bd
|
112 days
|
TMP/SMX 960 mg bd
|
Doxycycline
|
22 (Radhakrishna, 2014) [17]
|
7 years
|
Meropenem 2 g tds
|
Approx 56 days
|
Doxycycline followed by amoxycillin/clavulanic acid (doxycycline allergy)
|
12 months
|
Ceftazidime 3 g tds
|
Tobramycin (neb) 80 mg bd
|
TMP/SMX 960 mg bd
|
9 (Holland, 2002) [16] Infection 1
|
Unknown
|
Ceftazidime
|
14 days
|
TMP/SMX 960 mg bd
|
90 days
|
TMP/SMX 960 mg bd
|
9 (Holland, 2002) [16] Infection 2
|
1 month
|
Ceftazidime
|
21 days
|
TMP/SMX 960 mg bd
|
90 days
|
TMP/SMX 960 mg bd
|
9 (Holland, 2002) [16] Infection 3
|
1-2 months
|
Ceftazidime
|
14 days
|
TMP/SMX 960 mg bd
|
90 days
|
TMP/SMX 960 mg bd
|
Failed Eradication
|
8 (O’Carroll, 2003) [12]
|
4 months
|
Meropenem 2 g tds
|
56 days
|
None
| |
Ceftazidime 3 g tds
|
17
|
6-12 months
|
Ceftazidime 3 g tds
|
14 days
|
TMP/SMX 960 mg bd
|
84 days
|
TMP/SMX 960 mg bd
|
23
|
>10 months
|
Ceftazidime 3 g tds
|
21 days
|
Unknown (patient moved to Malaysia)
| |
TMP/SMX 960 mg bd
|
Tobramycin 5 mg/kg
|
3 (Schülin, 2001) [14]
|
6 years
|
Unspecified antipseudomonal antibiotics
|
14 days
|
No (exacerbations directed against PsA)
| |
14 (Barth, 2007) [9]
|
>18 months
|
Pipracillin/clavulanate
|
21 days
|
Meropenem 2 g tds
|
21 days
|
Tobramycin 5 mg/kg
|
Ceftazidime 3 g tds
|
Amikacin
|
TMP/SMX 960 mg bd
|
15
|
>8 years
|
Meropenem 2 g tds
|
14 days
|
TMP/SMX 960 mg bd
|
126 days
|
Tobramycin
|
Minocycline 100 mg bd
|
Meropenem (neb)
|
18 (1st attempt)
|
2 months
|
Ceftazidime 1.5 g tds
|
14 days
|
Infection not cleared therefore 2nd course of IV antibiotics
| |
Tobramycin 300 mg
|
Amoxycillin/Clavulanic acid 900 mg
|
18 (2nd attempt)
|
2 months
|
Meropenem
|
84 days
|
TMP/SMX 960 mg bd
|
Long term
|
Ceftazidime
|
Doxycycline
|
Amoxycillin/Clavulanic acid
|
6 (Holland, 2002) [16]
|
>4 years
|
Ceftazidime 50 mg/kg
|
120 days
|
None (exacerbations directed against B. pseudomallei)
| |
Piperacillin 50 mg/kg
|
Amoxycillin/Clavulanic acid
|
7 (Holland, 2002) [16]
|
>5 years
| | |
TMP/SMX 960 mg bd
|
4 years
|
1st isolation
|
7 (Holland, 2002) [16]
|
>9 years
|
Imipenem
|
20 days
|
TMP/SMX 960 mg bd
|
19 days
|
2nd isolation
|
Piperacillin/Clavulanic acid
|
42 days
|
Tetracycline
|
30 days
|
Meropenem/TMP/SMX
|
>30 days
|
11 (Holland, 2002) [16]
|
3 months
|
Ceftazidime
|
14 days
|
TMP/SMX 960 mg bd
|
330 days
|
Tobramycin
|
21
|
1 month
|
Meropenem 2 g tds
|
42 days
|
Tobramycin (neb) 300 mg bd
|
42 days
|
Ceftazidime 3 g tds
|
TMP/SMX 960 mg bd
|
Tobramycin 7 mg/kg
|